{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:09:16Z","timestamp":1787987356295,"version":"build-2784847793"},"reference-count":18,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K07005"],"award-info":[{"award-number":["20K07005"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.xphs.2023.05.013","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T01:57:33Z","timestamp":1684893453000},"page":"2591-2595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of Function and Features of Human Induced Pluripotent Stem Cell-Derived Small Intestinal Epithelial Cells for Analyzing Peptide Drug Intestinal Absorption Profiles"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3003-3586","authenticated-orcid":false,"given":"Mai","family":"Itagaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyasu","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Takeda-Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.xphs.2023.05.013_bib0001","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.3390\/jcm9062004","article-title":"Antisense oligonucleotides: an emerging area in drug discovery and development","volume":"9","author":"Dhuri","year":"2020","journal-title":"J Clin Medicine"},{"issue":"10","key":"10.1016\/j.xphs.2023.05.013_bib0002","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.3390\/ijms20102383","article-title":"Comprehensive review on current advances in peptide drug development and design","volume":"20","author":"Lee","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"467","key":"10.1016\/j.xphs.2023.05.013_bib0003","doi-asserted-by":"crossref","first-page":"eaar7047","DOI":"10.1126\/scitranslmed.aar7047","article-title":"Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist","volume":"10","author":"Buckley","year":"2018","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/j.xphs.2023.05.013_bib0004","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1080\/17425247.2021.1942838","article-title":"Transient Permeation Enhancer\u00ae (TPE\u00ae) technology for oral delivery of octreotide: a technological evaluation","volume":"18","author":"Brayden","year":"2021","journal-title":"Expert Opin Drug Del"},{"issue":"1","key":"10.1016\/j.xphs.2023.05.013_bib0005","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1208\/s12248-014-9687-3","article-title":"Strategic approaches to optimizing peptide ADME properties","volume":"17","author":"Di","year":"2015","journal-title":"Aaps J"},{"key":"10.1016\/j.xphs.2023.05.013_bib0006","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.addr.2016.07.007","article-title":"Oral absorption of peptides and nanoparticles across the human intestine: opportunities, limitations and studies in human tissues","volume":"106","author":"Lundquist","year":"2016","journal-title":"Adv Drug Deliver Rev"},{"issue":"1-3","key":"10.1016\/j.xphs.2023.05.013_bib0007","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0169-409X(00)00128-9","article-title":"Caco-2 monolayers in experimental and theoretical predictions of drug transport","volume":"46","author":"Artursson","year":"2001","journal-title":"Adv Drug Deliver Rev"},{"issue":"4","key":"10.1016\/j.xphs.2023.05.013_bib0008","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/17425255.4.4.395","article-title":"The Caco-2 cell monolayer: usefulness and limitations","volume":"4","author":"Sun","year":"2008","journal-title":"Expert Opin Drug Met"},{"issue":"10","key":"10.1016\/j.xphs.2023.05.013_bib0009","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1023\/A:1020483911355","article-title":"Comparison of human duodenum and caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs","volume":"19","author":"Sun","year":"2002","journal-title":"Pharmaceut Res"},{"issue":"4","key":"10.1016\/j.xphs.2023.05.013_bib0010","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.dmpk.2020.04.334","article-title":"Pharmacokinetic functions of human induced pluripotent stem cell-derived small intestinal epithelial cells","volume":"35","author":"Kabeya","year":"2020","journal-title":"Drug Metab Pharmacok"},{"issue":"2","key":"10.1016\/j.xphs.2023.05.013_bib0011","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2006.12.022","article-title":"A novel approach using functional peptides for efficient intestinal absorption of insulin","volume":"118","author":"Morishita","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2023.05.013_bib0012","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejpb.2020.08.001","article-title":"Effects of intestinal luminal contents and the importance of microfold cells on the ability of cell-penetrating peptides to enhance epithelial permeation of insulin","volume":"155","author":"Kamei","year":"2020","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1016\/j.xphs.2023.05.013_bib0013","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2008.08.001","article-title":"Usefulness of cell-penetrating peptides to improve intestinal insulin absorption","volume":"132","author":"Kamei","year":"2008","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.xphs.2023.05.013_bib0014","doi-asserted-by":"crossref","first-page":"e12571","DOI":"10.1111\/jfbc.12571","article-title":"Influence of peptide characteristics on their stability, intestinal transport, and in vitro bioavailability: a review","volume":"43","author":"Wang","year":"2019","journal-title":"J Food Biochem"},{"key":"10.1016\/j.xphs.2023.05.013_bib0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.peptides.2017.12.014","article-title":"Oral delivery of anti-diabetes therapeutics using cell penetrating and transcytosing peptide strategies","volume":"100","author":"Rehmani","year":"2018","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.xphs.2023.05.013_bib0016","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/bcpt.12515","article-title":"Cell-penetrating peptides as carriers for oral delivery of biopharmaceuticals","volume":"118","author":"Kristensen","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"4","key":"10.1016\/j.xphs.2023.05.013_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2021.140604","article-title":"Challenge to overcome current limitations of cell-penetrating peptides","volume":"1869","author":"Kim","year":"2021","journal-title":"Biochim Biophys Acta Protein Proteom"},{"key":"10.1016\/j.xphs.2023.05.013_bib0018","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2016.03.020","article-title":"Cell-penetrating peptides as noninvasive transmembrane vectors for the development of novel multifunctional drug-delivery systems","volume":"229","author":"Zhang","year":"2016","journal-title":"J Control Release"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923002009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923002009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:42:45Z","timestamp":1758361365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354923002009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0022354923002009"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2023.05.013","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Function and Features of Human Induced Pluripotent Stem Cell-Derived Small Intestinal Epithelial Cells for Analyzing Peptide Drug Intestinal Absorption Profiles","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2023.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}